Prolonged response to first‐generation tyrosine kinase inhibitor in a metastatic non‐small cell lung cancer harbouring complex G719X and S768I mutations: A case report from Vietnam and literature review

Abstract A complex of G719X and S768I mutations is infrequently observed, constituting less than 0.3% of all EGFR‐positive non‐small cell lung cancer (NSCLC), and the response to first‐line TKIs is inconsistent in the literature. In this study, we report a patient with metastatic non‐small cell lung...

Full description

Bibliographic Details
Main Authors: Kien Hung Do, Duc Thanh Le, Tai Van Nguyen, Tu Anh Do, Chu Van Nguyen
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:Respirology Case Reports
Subjects:
Online Access:https://doi.org/10.1002/rcr2.1131
_version_ 1797839725621411840
author Kien Hung Do
Duc Thanh Le
Tai Van Nguyen
Tu Anh Do
Chu Van Nguyen
author_facet Kien Hung Do
Duc Thanh Le
Tai Van Nguyen
Tu Anh Do
Chu Van Nguyen
author_sort Kien Hung Do
collection DOAJ
description Abstract A complex of G719X and S768I mutations is infrequently observed, constituting less than 0.3% of all EGFR‐positive non‐small cell lung cancer (NSCLC), and the response to first‐line TKIs is inconsistent in the literature. In this study, we report a patient with metastatic non‐small cell lung cancer carrying rare EGFR compound mutations of G719X and S768I who benefited from first‐line treatment with gefitinib in Vietnam. This patient had a prolonged response lasting over 44 months with first‐generation TKI. He continued to take gefitinib without experiencing serious adverse events. NSCLC with a rare complex of G719X and S768I mutation revealed a good response to gefitinib.
first_indexed 2024-04-09T16:01:41Z
format Article
id doaj.art-55b592de4abc4787874ec8b7836ae75b
institution Directory Open Access Journal
issn 2051-3380
language English
last_indexed 2024-04-09T16:01:41Z
publishDate 2023-05-01
publisher Wiley
record_format Article
series Respirology Case Reports
spelling doaj.art-55b592de4abc4787874ec8b7836ae75b2023-04-25T09:44:35ZengWileyRespirology Case Reports2051-33802023-05-01115n/an/a10.1002/rcr2.1131Prolonged response to first‐generation tyrosine kinase inhibitor in a metastatic non‐small cell lung cancer harbouring complex G719X and S768I mutations: A case report from Vietnam and literature reviewKien Hung Do0Duc Thanh Le1Tai Van Nguyen2Tu Anh Do3Chu Van Nguyen4National Cancer Hospital Hanoi VietnamNational Cancer Hospital Hanoi VietnamNational Cancer Hospital Hanoi VietnamNational Cancer Hospital Hanoi VietnamNational Cancer Hospital Hanoi VietnamAbstract A complex of G719X and S768I mutations is infrequently observed, constituting less than 0.3% of all EGFR‐positive non‐small cell lung cancer (NSCLC), and the response to first‐line TKIs is inconsistent in the literature. In this study, we report a patient with metastatic non‐small cell lung cancer carrying rare EGFR compound mutations of G719X and S768I who benefited from first‐line treatment with gefitinib in Vietnam. This patient had a prolonged response lasting over 44 months with first‐generation TKI. He continued to take gefitinib without experiencing serious adverse events. NSCLC with a rare complex of G719X and S768I mutation revealed a good response to gefitinib.https://doi.org/10.1002/rcr2.1131first‐generation TKIsG719X and S768I mutationsNSCLCrare EGFR mutation
spellingShingle Kien Hung Do
Duc Thanh Le
Tai Van Nguyen
Tu Anh Do
Chu Van Nguyen
Prolonged response to first‐generation tyrosine kinase inhibitor in a metastatic non‐small cell lung cancer harbouring complex G719X and S768I mutations: A case report from Vietnam and literature review
Respirology Case Reports
first‐generation TKIs
G719X and S768I mutations
NSCLC
rare EGFR mutation
title Prolonged response to first‐generation tyrosine kinase inhibitor in a metastatic non‐small cell lung cancer harbouring complex G719X and S768I mutations: A case report from Vietnam and literature review
title_full Prolonged response to first‐generation tyrosine kinase inhibitor in a metastatic non‐small cell lung cancer harbouring complex G719X and S768I mutations: A case report from Vietnam and literature review
title_fullStr Prolonged response to first‐generation tyrosine kinase inhibitor in a metastatic non‐small cell lung cancer harbouring complex G719X and S768I mutations: A case report from Vietnam and literature review
title_full_unstemmed Prolonged response to first‐generation tyrosine kinase inhibitor in a metastatic non‐small cell lung cancer harbouring complex G719X and S768I mutations: A case report from Vietnam and literature review
title_short Prolonged response to first‐generation tyrosine kinase inhibitor in a metastatic non‐small cell lung cancer harbouring complex G719X and S768I mutations: A case report from Vietnam and literature review
title_sort prolonged response to first generation tyrosine kinase inhibitor in a metastatic non small cell lung cancer harbouring complex g719x and s768i mutations a case report from vietnam and literature review
topic first‐generation TKIs
G719X and S768I mutations
NSCLC
rare EGFR mutation
url https://doi.org/10.1002/rcr2.1131
work_keys_str_mv AT kienhungdo prolongedresponsetofirstgenerationtyrosinekinaseinhibitorinametastaticnonsmallcelllungcancerharbouringcomplexg719xands768imutationsacasereportfromvietnamandliteraturereview
AT ducthanhle prolongedresponsetofirstgenerationtyrosinekinaseinhibitorinametastaticnonsmallcelllungcancerharbouringcomplexg719xands768imutationsacasereportfromvietnamandliteraturereview
AT taivannguyen prolongedresponsetofirstgenerationtyrosinekinaseinhibitorinametastaticnonsmallcelllungcancerharbouringcomplexg719xands768imutationsacasereportfromvietnamandliteraturereview
AT tuanhdo prolongedresponsetofirstgenerationtyrosinekinaseinhibitorinametastaticnonsmallcelllungcancerharbouringcomplexg719xands768imutationsacasereportfromvietnamandliteraturereview
AT chuvannguyen prolongedresponsetofirstgenerationtyrosinekinaseinhibitorinametastaticnonsmallcelllungcancerharbouringcomplexg719xands768imutationsacasereportfromvietnamandliteraturereview